LENZ Therapeutics, Inc. (LENZ)
5.34
+0.11
(+2.10%)
USD |
NASDAQ |
Sep 02, 14:16
LENZ Therapeutics Cash from Operations (Annual) : -69.17M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -69.17M |
| December 31, 2024 | -59.39M |
| December 31, 2023 | -60.38M |
| December 31, 2022 | -87.98M |
| Date | Value |
|---|---|
| December 31, 2021 | -52.85M |
| December 31, 2020 | -8.721M |
| December 31, 2019 | -0.019M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Ocular Therapeutix, Inc. | -204.88M |
| Enveric Biosciences, Inc. | -8.142M |
| Liquidia Corp. | -35.69M |
| Aquestive Therapeutics, Inc. | -52.43M |
| Impact BioMedical, Inc. | -1.89M |